antibody, the amino acid sequence for SDCBP was run through two epitope
prediction tools (Bepipred Linear Epitope Prediction 2.0 and ABCPred) to
determine predicted epitopes. Predicted targetable extracellular domains were
chosen as the peptides for tetramer analysis. We tetramerized two biotinylated
peptides (GenScript) contained in the extracellular domain of syndecan binding
protein (SDCBP) using PE-labelled fluorescent streptavidin (BioLegend, 405203)
and used flow cytometry to determine the percent of specific antigen-reactive
immortalized B cells which are secreting antibodies against the target molecule
from each of the six immortalized B cell lines, using the protocol previously
described.5 (link) We then
used fluorescence-activated cell sorting with EEEIRANVAVVSGAPL peptide to sort
endometrioid carcinoma-derived immortalized B cells specific for SDCBP from the
pool of immortalized B cells.